http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2360698-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| filingDate | 2008-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e2c2d56f2f1f50d471d473fc081730 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d22e078fd5edc4dd79cfa26f122622c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_538abe084cb8ff404cb990b7bc8e88d0 |
| publicationDate | 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2360698-C1 |
| titleOfInvention | Bronchial asthma treatment mode |
| abstract | FIELD: medicine. n SUBSTANCE: treatment of the patients suffering from bronchial asthma involves basic therapy combined with Rusam. Additionally, sodium nucleinate is prescribed in a dose 0.5 g daily twice a day within 20 days and capsulated Hypoxene dosed 0.1-0.2 g a day, daily within 7 days. n EFFECT: scheduled introduction of such drug combination allows improving clinical effectiveness, including due to selective effect on the certain links of immune system and desensitisation through induction of specific immune response on introduction of Rusam, its enchancement with sodium nucleinate and elimination of hypoxic conditions. n 1 tbl, 1 ex |
| priorityDate | 2008-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.